课题基金 / 基金详情

Relationship between rheumatoid arthritis and osteoporosis.

Relationship between rheumatoid arthritis and osteoporosis.
类风湿性关节炎与骨质疏松症的关系。
批准号:
16591479
负责人:
ARAI Katsumitsu
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

ARAI Katsumitsu的其他基金

相似基金

相关文献

中文摘要
翻译
类风湿性关节炎患者有广泛性骨质疏松症的报道。然而,尚不确定这是由于疾病本身还是由于类固醇治疗或缺乏运动等相关因素。我们分析糖皮质激素对8周龄大鼠胫骨骨髓消融后骨再生的影响。甲泼尼龙琥珀酸钠(MPSS)以100mg /kg/天的剂量肌肉注射,连续3天。消融后第1、3、5、7、10、12、14天胫骨行抗酒石酸酸性磷酸酶(TRAP)染色、免疫组化、原位杂交、透射电镜(TEM),测定新生骨体积和破骨细胞数量。MPSS处理组第7天新生骨体积明显减少,第10天仍有未成熟骨存在。该骨的体积明显高于对照组。但各组间破骨细胞数量、成骨细胞分化标志物mrna表达、碱性磷酸酶和组织蛋白酶K免疫组化检测均无差异。TEM结果显示,成骨细胞的形态没有差异,而与对照组相比,mpss治疗组的破骨细胞有较少的褶皱边界。这些结果表明,MPSS治疗既不影响成骨细胞的分化,也不影响成骨细胞的形态,也不改变破骨细胞的数量和组织蛋白酶K水平。然而,大剂量MPSS抑制大鼠胫骨骨髓消融后骨再生过程中的骨形成和骨吸收,抑制破骨细胞皱边形成。这些数据将有助于开发骨再生疗法的骨疾病,由于高剂量类固醇给药。
英文摘要
Generalized osteoporosis has been reported in patients with rheumatoid arthritis. However, it is uncertain whether this is due to the disease itself or to related factors such as steroid treatment or inactivity. We analyzed the effect of glucocorticoid on bone regeneration after bone marrow ablation in tibiae of eight-week-old rats. Methylprednisolone sodium succinate (MPSS) was injected intramuscularly at a dose of 100 mg/kg/day for 3 days. Tibiae on days 1, 3, 5, 7, 10, 12 and 14 after ablation were subjected to tartrate-resistant acid phosphatase (TRAP) staining, immunohistochemistry, in situ hybridization, and transmission electron microscopy (TEM), and measurement of the volume of newly-formed bone and the osteoclast number. MPSS significantly decreased the newly-formed bone volume on day 7, and immature bone still remained on day 10 in the MPSS-treated group. The volume of this bone was significantly higher than that in the control group. However, there were no differences between the groups in the osteoclast number, the expression of mRNAs for osteoblast differentiation markers, and alkaline phosphatase and cathepsin K judged by immunohistochemistry. TEM findings showed no difference in the form of osteoblasts, whereas osteoclasts in the MPSS-treated group had less developed ruffled borders, compared to those in the control group. These results suggest that MPSS treatment affects neither the differentiation nor the shape of osteoblasts, and does not change the osteoclast number or the cathepsin K level. However, high dose MPSS inhibits both bone formation and resorption during bone regeneration after rat tibial bone marrow ablation, and inhibits ruffled border formation in osteoclasts. These data will be useful to develop bone regenerative therapies for bone diseases due to high dose steroid administration.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s00774-005-0657-9
发表时间: 2006-03-01
期刊: JOURNAL OF BONE AND MINERAL METABOLISM
影响因子: 3.3
作者: [Arai, K, Hanyu, T, Endo, N]
通讯作者: Endo, N
骨髄損傷後骨再生モデルにおけるステロイドの影響
类固醇对骨髓损伤后骨再生模型的影响
DOI: --
发表时间: 2005
期刊: 別冊整形外科 48
影响因子: --
作者: [Nankaku M, Kanzaki H, Tsuboyama T, Nakamura T, 石崎 明, 近藤直樹]
通讯作者: 近藤直樹
Bone formation and resorption of highly purified B-tricalcium phosphate in the rat femoral condyle
高纯度B-磷酸三钙在大鼠股骨髁中的骨形成和吸收
DOI: --
发表时间: 2005
期刊: Biomaterials 26
影响因子: --
作者: [Kondo N, et al.]
通讯作者: et al.
Gluticocorticoid inhibits bone formation an resorption in bone regeneration after bone marrow ablation of rat tibia
糖皮质激素抑制大鼠胫骨骨髓消融后骨形成和骨再生吸收
DOI: --
发表时间: 2005
期刊: Bessatsu Seikeigeka (Japanese) 48
影响因子: --
作者: [Kondo N, et al.]
通讯作者: et al.
6
    Gene transfer therapy trial of Chondromodulin I for the experimental arthritis
    • 批准号:
      14571363
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2002
    • 负责人:
      ARAI Katsumitsu
    • 依托单位:
    国内基金
    海外基金
    基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
    • 批准号:
      82371373
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      沃雁
    • 依托单位:
    利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
    • 批准号:
      82371145
    • 项目类别:
      面上项目
    • 资助金额:
      46.00万元
    • 批准年份:
      2023
    • 负责人:
      陶永
    • 依托单位:
    生理/病理应激差异化调控肝再生的“蓝斑—中缝”神经环路机制
    • 批准号:
      82371517
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      杨立群
    • 依托单位:
    LIPUS响应的弹性石墨烯多孔导管促进神经再生及其机制研究
    • 批准号:
      82370933
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      陆家瑜
    • 依托单位: